What's more troublesome is that the process is complex, yields are low, and it may use toxic and harmful reagents like formaldehyde and methyl iodide, so safety has always been an issue. 2. Natural biological extraction: direct extraction from edible mushrooms such as porcini, shiitake, and enoki. But the ergothioneine content in these raw materials is generally only 0.1–3 mg/g (dry weight), extremely low. To extract enough of the compound requires massive amounts of raw material, with high extraction costs, complex purification processes, and limitations from raw material sources and growth cycles—making large-scale production fundamentally impossible. 3. Biosynthesis (microbial fermentation): using synthetic biology to construct efficient engineered strains like E. coli and yeast as "cell factories," synthesizing ergothioneine through fermentation. The advantages of this route are obvious: high optical specificity of the product, good bioavailability, a mild and green production process with no solvent pollution, suitable for industrial large-scale production, and controllable costs. With its comprehensive advantages of high purity, high activity, and green sustainability, this has become the mainstream technical direction for ergothioneine production today. But even within biosynthesis, different companies' foundations and capabilities determine the ceiling of the final product. Zhongke Xinyang is a pioneer on this technical path. As one of the world's earliest companies to adopt fully synthetic microbial cell factory production of ergothioneine and achieve large-scale manufacturing, it holds a leading share of the domestic raw material market. Its flagship ingredient SIYOMICRO-ERGO® ergothioneine is different from other companies at the source: the strain comes from ultra-stable microorganisms collected from the extreme environment of the Quzhuomu hot spring in Tibet. Through AI enzyme screening and genetic engineering, the R&D team selected the best genes from tens of thousands of synthases to construct an engineered strain that efficiently synthesizes ergothioneine. The modified engineered bacteria are put into hundred-ton fermentation tanks, using fully synthetic microbial cell factory technology, with large-scale fermentation culture under precisely controlled temperature, pH, dissolved oxygen, and other conditions.
Erythritol: made from starch such as wheat and corn through safe, food-grade osmophilic yeasts like Moniliella pollinis, Candida lipolytica, or Trichosporonoides megachilensis, which undergo enzymatic fermentation at high concentration (>450 g/L); the fermentation broth is then heat-sterilized and filtered, purified through ion-exchange resin, activated carbon, and ultrafiltration, then crystallized, washed, and dried. Typical yield is about 50%.
White crystals, slightly sweet, relative sweetness 0.65.
Cooling sensation.
Low calorie content, about one-tenth that of sucrose.
Soluble in water (37%, 25°C); because of its lower solubility (compared to sucrose) it crystallizes easily, making it suitable for foods that need a sucrose mouthfeel, like chocolate and table sugar.
Not degraded by enzymes; it's only excreted from blood to urine through the kidneys (easily absorbed by the small intestine), doesn't participate in sugar metabolism or affect blood sugar, so it's suitable for diabetics.
3) Couple Fmoc-protected α-amino glycine onto the solid-phase synthesis resin, remove the Fmoc protecting group, then sequentially couple Fmoc- or Boc-protected α-amino acids or peptide fragments, removing the Fmoc group after each coupling. The coupling order for the Fmoc- or Boc-protected α-amino acids or peptide fragments is: Fmoc-Arg(Pbf)-OH, Fmoc-Gly-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Val-OH, Fmoc-Leu-OH, Fmoc-Trp(Boc)-OH, Fmoc-Ala-OH, Fmoc-Ile-OH, Fmoc-Phe-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Lys(X)-OH, Fmoc-Ala-OH, Fmoc-Ala-OH, Fmoc-Gln(Trt)-OH, Fmoc-Gly-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Leu-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Ser(Trt)-OH, Fmoc-Val-OH, Fmoc-Asp(Y)-OH, Fmoc-Ser(Trt)-OH, Fmoc-Thr(tBu)-OH, Fmoc-Thr(tBu)-Phe-OH; Fmoc-Gly-OH, Fmoc-Glu(OtBu)-OH, Boc-His(Trt)-Aib-OH; or Fmoc-Arg(Pbf)-OH, Fmoc-Gly-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Val-OH, Fmoc-Leu-OH, Fmoc-Trp(Boc)-OH, Fmoc-Ala-OH, Fmoc-Ile-OH, Fmoc-Phe-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Lys(X)-OH, Fmoc-Ala-OH, Fmoc-Ala-OH, Fmoc-Gln(Trt)-OH, Fmoc-Gly-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Leu-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Ser(Trt)-OH, Fmoc-Val-OH, Fmoc-Asp(Y)-OH, Fmoc-Ser(Trt)-OH, Fmoc-Thr(tBu)-OH, Fmoc-Thr(tBu)-Phe-OH, Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH; or Fmoc-Arg(Pbf)-OH, Fmoc-Gly-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Val-OH, Fmoc-Leu-OH, Fmoc-Trp(Boc)-OH, Fmoc-Ala-OH, Fmoc-Ile-OH, Fmoc-Phe-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Lys(X)-OH, Fmoc-Ala-OH, Fmoc-Ala-OH, Fmoc-Gln(Trt)-OH, Fmoc-Gly-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Leu-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Ser(Trt)-OH, Fmoc-Val-OH, Fmoc-Asp(Y)-OH, Fmoc-Ser(Trt)-OH, Fmoc-Thr(tBu)-OH, Fmoc-Thr(tBu)-Phe-OH, Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OSu; 4) remove the X protecting group from Lys(X); 5) couple Fmoc-AEEA-OH, then sequentially couple Fmoc-AEEA-OH, Fmoc-Glu-OtBu, and monoterbutyl octadecanedioate by removing the Fmoc group and coupling; 6) cleave the resin and side-chain protecting groups to get the crude peptide; 7) purify to obtain purified semaglutide.